Back to search
Choroidal Melanoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Choroidal Melanoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Choroidal Melanoma trials you may qualify forThis is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminat…
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that ha…
The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, stan…
This phase II trial studies the effect of transarterial chemoembolization in treating patients with uveal melanoma that has spread to the liver (liver metastase…
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma
This randomized phase II trial studies how well sunitinib malate or valproic acid works in preventing high-risk uveal (eye) melanoma from spreading to other par…